Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Trial of Degarelix in Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT00946920

Public ClinicalTrials.gov record NCT00946920. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 2:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multi-Centre, Randomised, Parallel-Arm One-Year Trial, Comparing the Efficacy and Safety of Degarelix Three-Month Dosing Regimen With Goserelin Acetate in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A phase 3, open-label, parallel group, one year trial comparing the efficacy and safety of degarelix 3-month depot with the established therapy goserelin acetate 3-month implant in patients with prostate cancer.

Study identification

NCT ID
NCT00946920
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
859 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2009
Primary completion
Feb 28, 2011
Completion
Feb 28, 2011
Last update posted
Jun 1, 2014

2009 – 2011

United States locations

U.S. sites
36
U.S. states
19
U.S. cities
35
Facility City State ZIP Site status
Urology Centers Of Alabama Homewood Alabama
Arkansas Urology Little Rock Arkansas
Urology Associates of Central CA Fresno California
Medresearch La Mesa California
South Orange County Medical Research Center Laguna Hills California
Atlantic Urology Medical Group Long Beach California
Anschutz Cancer Pavillion Aurora Colorado
The Urology Center of Colorado Denver Colorado
Urological Associates of Bridgeport, P.C. Trumbull Connecticut
Urology Associates of Dover, PA Dover Delaware
Walter Reed Army Medical Center Washington D.C. District of Columbia
South Florida Medical Research Aventura Florida
Florida Foundation for Healthcare Research Ocala Florida
Georgis Patsias, MD, PA Wellington Florida
Palm Beach Urology Associates, PA Wellington Florida
Indiana University Department of Urology Indianapolis Indiana
Kansas City Urology Care, PA Overland Park Kansas
Urological Associates of Englewood Englewood New Jersey
Hamilton Urology PA Hamilton New Jersey
Lawrenceville Urology Lawrenceville New Jersey
Urology Group of New Mexico, PC Albuquerque New Mexico
Capital Region Urological Surgeons and Research Associates Albany New York
Hudson Valley Urology P.C. Poughkeepsie New York
Metrolina Urology Clinic Charlotte North Carolina
Northeast Urology Research Concord North Carolina
Duke University Medical Center Durham North Carolina
Alliance Urology Specialists Greensboro North Carolina
Urologic Consultants of SEPA Bala-Cynwyd Pennsylvania
State College Urologic Association State College Pennsylvania
Grand Strand Urology Myrtle Beach South Carolina
Urology Clinics of North Texas, PA Dallas Texas
Urology San Antonio Research San Antonio Texas
Urology of Virginia Norfolk Virginia
Virginia Urology Center Richmond Virginia
Urology of Virginia Virginia Beach Virginia
Seattle Urology Research Center Burien Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 90 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00946920, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2014 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00946920 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →